Cytogenetic tests: Difference between revisions
Jump to navigation
Jump to search
→ISH: more |
m →ISH: w |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 17: | Line 17: | ||
|- | |- | ||
| BCR/ABL1 | | BCR/ABL1 | ||
| CML or ALL | | [[CML]] or ALL | ||
| Tx | | Tx: [[imatinib]] | ||
|- | |- | ||
| MLL<ref>{{OMIM|159555}}</ref> | | MLL<ref>{{OMIM|159555}}</ref> | ||
| Line 48: | Line 48: | ||
| ERBB2 (HER2) | | ERBB2 (HER2) | ||
| [[breast cancer]] | | [[breast cancer]] | ||
| prognostic, Tx (trastuzumab) | | prognostic, Tx ([[trastuzumab]]) | ||
|- | |- | ||
| EWSR1 | | EWSR1 | ||